These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3534845)

  • 1. Low dose captopril twice daily lowers blood pressure without disturbance of the normal circadian rhythm.
    Meijer JL; Ardesch HG; van Rooijen JC; de Bruijn JH
    Postgrad Med J; 1986; 62 Suppl 1():101-5. PubMed ID: 3534845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring.
    Cheung DG; Gasster JL; Weber MA
    Arch Intern Med; 1989 Sep; 149(9):2021-5. PubMed ID: 2673118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring.
    Podjarny E; Korzets Z; Bernheim J
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S153-6. PubMed ID: 8872849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure effects of the angiotensin II receptor blocker, losartan.
    Weber MA; Byyny RL; Pratt JH; Faison EP; Snavely DB; Goldberg AI; Nelson EB
    Arch Intern Med; 1995 Feb; 155(4):405-11. PubMed ID: 7848024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of amlodipine and captopril in hypertension based on 24-hour ambulatory monitoring.
    Lacourcière Y; Poirier L; Provencher P
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S20-3. PubMed ID: 7522283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily treatment of essential hypertension with captopril.
    Schoenberger JA; Wilson DJ
    J Clin Hypertens; 1986 Dec; 2(4):379-87. PubMed ID: 3543231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
    Zanchetti A
    J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the efficacy of captopril at a single daily dose of 100 mg and at a twice daily dose of 50 mg by measuring ambulatory pressure over 24 hours.
    De Gaudemaris R; Battistella P; Siche JP; Debru JL; Blatier JF; Mallion JM
    Postgrad Med J; 1986; 62 Suppl 1():97-100. PubMed ID: 3534869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of trandolapril on 24-h ambulatory blood pressure in patients with mild-to-moderate essential hypertension.
    Cesarone MR; De Sanctis MT; Laurora G; Ambrosoli L; Marelli C; Belcaro G
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S65-72. PubMed ID: 7527105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients.
    Hansen KW; Klein F; Christensen PD; Sørensen K; Andersen PH; Møller J; Pedersen EB; Christiansen JS; Mogensen CE
    Diabete Metab; 1994; 20(5):485-93. PubMed ID: 7859897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of captopril once daily on blood pressure and angiotensin converting enzyme in hypertensive patients.
    Rodriguez FJ; Gil V; del Carmen Beneyto M; Lopez-Vidriero E
    Postgrad Med J; 1986; 62 Suppl 1():94-6. PubMed ID: 2825151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
    Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
    J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of trandolapril and captopril for 16 weeks in mild-to-moderate essential hypertension. Investigator Study Group.
    Pauly NC; Safar ME
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S73-6. PubMed ID: 7527106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [24-hour blood pressure monitoring. Results with captopril once a day].
    Puhlmann WH; Strüder P
    Fortschr Med; 1990 Nov; 108(34):660-2. PubMed ID: 2289738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
    Kukushkin SK; Lebedev AV; Manoshkina EM; Shamarin VM
    Ter Arkh; 1998; 70(9):69-71. PubMed ID: 9821232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril/hydrochlorothiazide combination in elderly patients with mild-moderate hypertension. A double-blind, randomized, placebo-controlled study.
    Creisson C; Baulac L; Lenfant B
    Postgrad Med J; 1986; 62 Suppl 1():139-41. PubMed ID: 3534849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous ambulatory measurement of blood pressure in children--personal experience].
    Peco-Antić A; Pejcić I; Stojanov V; Kostić M; Kruscić D; Jovanović O; Mancić J
    Srp Arh Celok Lek; 1997; 125(7-8):197-202. PubMed ID: 9304231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.